Cargando…
COVID-19 impact on the diagnosis of Inborn Errors of Metabolism: Data from a reference center in Brazil
The COVID-19 pandemic led to the reorganization of health care in several countries, including Brazil. Inborn Errors of Metabolism (IEM) are a group of rare and difficult to diagnose genetic diseases caused by pathogenic variants in genes that code for enzymes, cofactors, or structural proteins affe...
Autores principales: | Sebastião, Fernanda Medeiros, Michelin-Tirelli, Kristiane, Bender, Fernanda, Lopes, Franciele Fátima, Moraes, Inamara, Kubaski, Francyne, Giugliani, Roberto, Burin, Maira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Genética
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691104/ https://www.ncbi.nlm.nih.gov/pubmed/34927665 http://dx.doi.org/10.1590/1678-4685-GMB-2021-0253 |
Ejemplares similares
-
Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays
por: Bender, Fernanda, et al.
Publicado: (2020) -
Updated birth prevalence and relative frequency of
mucopolysaccharidoses across Brazilian regions
por: Josahkian, Juliana Alves, et al.
Publicado: (2021) -
Relative frequency and estimated minimal frequency of Lysosomal Storage
Diseases in Brazil: Report from a Reference Laboratory
por: Giugliani, Roberto, et al.
Publicado: (2017) -
Diagnosis of Mucopolysaccharidoses
por: Kubaski, Francyne, et al.
Publicado: (2020) -
Experience of the NPC Brazil Network with a Comprehensive Program for the Screening and Diagnosis of Niemann-Pick Disease Type C
por: Kubaski, Francyne, et al.
Publicado: (2022)